Quotes 5-day view Delayed Xetra
10/19/2020
10/20/2020
10/21/2020
10/22/2020
10/23/2020
Date
124.3(c)
124.6(c)
125.05(c)
127.95(c)
131.85(c)
Last
290 119
352 191
590 424
663 160
662 407
Volume
-0.72% +0.24% +0.36% +2.32% +3.05% Change
Sales 2020
17 304 M 20 524 M 20 524 M
Net income 2020
1 706 M 2 023 M 2 023 M
Net Debt 2020
10 847 M 12 866 M 12 866 M
P/E ratio 2020
32,0x
Yield 2020
1,01%
Sales 2021
18 166 M 21 547 M 21 547 M
Net income 2021
2 113 M 2 506 M 2 506 M
Net Debt 2021
9 085 M 10 775 M 10 775 M
P/E ratio 2021
26,5x
Yield 2021
1,08%
Capitalization
57 325 M 67 857 M 67 994 M
EV / Sales 2020
3,94x
EV / Sales 2021
3,66x
Nbr of Employees
57 523
Free-Float
29,7%
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows:
- pharmaceutical products (41.6%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.;
- solutions and products for scientific and biotechnological research...
Notations Surperformance© of Merck KGaA
Trading Rating : Investor Rating :
All news about MERCK KGAA
News in other languages on MERCK KGAA
Analyst Recommendations on MERCK KGAA
European stocks slide as Wall Street hit by virus surge
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends MERCK KGAA
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
22
Average target price
126,24 €
Last Close Price
131,85 €
Spread / Highest target
13,8%
Spread / Average Target
-4,25%
Spread / Lowest Target
-23,4%
Please enable JavaScript in your browser's settings to use dynamic charts.
1st jan. Capitalization (M$)
MERCK KGAA 25.15% 65 811
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report
